|
US7435802B2
(en)
|
1994-01-25 |
2008-10-14 |
Elan Pharaceuticals, Inc. |
Humanized anti-VLA4 immunoglobulins
|
|
US5840299A
(en)
*
|
1994-01-25 |
1998-11-24 |
Athena Neurosciences, Inc. |
Humanized antibodies against leukocyte adhesion molecule VLA-4
|
|
US6037324A
(en)
*
|
1996-01-04 |
2000-03-14 |
Leukosite, Inc. |
Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
|
|
NO970866L
(no)
*
|
1996-02-28 |
1997-08-29 |
Target Therapeutics Inc |
Infusjons-kateter med oppblåsbar membran
|
|
SE9603465D0
(sv)
*
|
1996-09-23 |
1996-09-23 |
Astra Ab |
New compounds
|
|
US6903075B1
(en)
|
1997-05-29 |
2005-06-07 |
Merck & Co., Inc. |
Heterocyclic amide compounds as cell adhesion inhibitors
|
|
US6221888B1
(en)
|
1997-05-29 |
2001-04-24 |
Merck & Co., Inc. |
Sulfonamides as cell adhesion inhibitors
|
|
US6291511B1
(en)
|
1997-05-29 |
2001-09-18 |
Merck & Co., Inc. |
Biarylalkanoic acids as cell adhesion inhibitors
|
|
WO1998054207A1
(en)
*
|
1997-05-30 |
1998-12-03 |
Celltech Therapeutics Limited |
Anti-inflammatory tyrosine derivatives
|
|
US6939855B2
(en)
|
1997-07-31 |
2005-09-06 |
Elan Pharmaceuticals, Inc. |
Anti-inflammatory compositions and method
|
|
US6559127B1
(en)
|
1997-07-31 |
2003-05-06 |
Athena Neurosciences, Inc. |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6069163A
(en)
*
|
1997-10-21 |
2000-05-30 |
Merck & Co., Inc. |
Azapeptide acids as cell adhesion inhibitors
|
|
WO1999025731A1
(fr)
*
|
1997-11-13 |
1999-05-27 |
Toray Industries, Inc. |
Peptides cycliques et leur utilisation medicinale
|
|
US6020347A
(en)
*
|
1997-11-18 |
2000-02-01 |
Merck & Co., Inc. |
4-substituted-4-piperidine carboxamide derivatives
|
|
US6191171B1
(en)
|
1997-11-20 |
2001-02-20 |
Merck & Co., Inc. |
Para-aminomethylaryl carboxamide derivatives
|
|
US6090841A
(en)
*
|
1997-11-21 |
2000-07-18 |
Merck & Co., Inc. |
Substituted pyrrole derivatives as cell adhesion inhibitors
|
|
US6645939B1
(en)
|
1997-11-24 |
2003-11-11 |
Merck & Co., Inc. |
Substituted β-alanine derivatives as cell adhesion inhibitors
|
|
US6197794B1
(en)
*
|
1998-01-08 |
2001-03-06 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
FR2773475B1
(fr)
|
1998-01-13 |
2001-02-02 |
Oreal |
Composition tinctoriale et procedes de teinture des fibres keratiniques la mettant en oeuvre
|
|
FR2773476B1
(fr)
|
1998-01-13 |
2001-02-23 |
Oreal |
Composition tinctoriale et procedes de teinture des fibres keratiniques la mettant en oeuvre
|
|
US6329372B1
(en)
|
1998-01-27 |
2001-12-11 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
GB9805655D0
(en)
|
1998-03-16 |
1998-05-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6521626B1
(en)
|
1998-03-24 |
2003-02-18 |
Celltech R&D Limited |
Thiocarboxamide derivatives
|
|
GB9811159D0
(en)
|
1998-05-22 |
1998-07-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9811969D0
(en)
|
1998-06-03 |
1998-07-29 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9814414D0
(en)
|
1998-07-03 |
1998-09-02 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9821061D0
(en)
|
1998-09-28 |
1998-11-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9821222D0
(en)
|
1998-09-30 |
1998-11-25 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9825652D0
(en)
|
1998-11-23 |
1999-01-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9826174D0
(en)
|
1998-11-30 |
1999-01-20 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
HK1045157A1
(zh)
|
1999-01-22 |
2002-11-15 |
依兰制药公司 |
抑制vla-4介导的白细胞粘着的化合物
|
|
TW593284B
(en)
|
1999-01-22 |
2004-06-21 |
Elan Pharm Inc |
Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
AR035838A1
(es)
*
|
1999-01-22 |
2004-07-21 |
Elan Pharm Inc |
Compuestos multiciclicos que inhiben la adhesion de leucocitos mediada por vla-4 y el uso de los mismos para la preparacion de un medicamento
|
|
US6436904B1
(en)
|
1999-01-25 |
2002-08-20 |
Elan Pharmaceuticals, Inc. |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
AU3348700A
(en)
*
|
1999-01-25 |
2000-08-07 |
American Home Products Corporation |
Compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
US6407066B1
(en)
|
1999-01-26 |
2002-06-18 |
Elan Pharmaceuticals, Inc. |
Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
JP2002535341A
(ja)
*
|
1999-01-26 |
2002-10-22 |
エラン ファーマシューティカルズ,インコーポレイテッド |
Vla−4により媒介される白血球接着を阻害するピログルタミン酸誘導体および関連化合物
|
|
AU3246600A
(en)
*
|
1999-03-01 |
2000-09-21 |
Elan Pharmaceuticals, Inc. |
Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7 receptor antagonists
|
|
US6518283B1
(en)
|
1999-05-28 |
2003-02-11 |
Celltech R&D Limited |
Squaric acid derivatives
|
|
EP1203026A4
(de)
*
|
1999-07-29 |
2005-03-16 |
Dyax Corp |
Bindungsstellen für fibrin
|
|
US6534513B1
(en)
|
1999-09-29 |
2003-03-18 |
Celltech R&D Limited |
Phenylalkanoic acid derivatives
|
|
AU783110B2
(en)
|
1999-12-16 |
2005-09-22 |
Biogen Ma Inc. |
Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
|
|
US6455539B2
(en)
|
1999-12-23 |
2002-09-24 |
Celltech R&D Limited |
Squaric acid derivates
|
|
YU41202A
(sh)
|
1999-12-28 |
2005-03-15 |
Pfizer Products Inc. |
Ne-peptidni inhibitori vezivanja za ćeliju zavisnog od vla-4 korisni pri tretiranju inflamatornih, autoimunih i respiratornih bolesti
|
|
DE60130910T2
(de)
|
2000-04-17 |
2008-07-10 |
Ucb Pharma, S.A. |
Enamin-derivate als zell-adhäsionsmoleküle
|
|
US6403608B1
(en)
|
2000-05-30 |
2002-06-11 |
Celltech R&D, Ltd. |
3-Substituted isoquinolin-1-yl derivatives
|
|
US6545013B2
(en)
|
2000-05-30 |
2003-04-08 |
Celltech R&D Limited |
2,7-naphthyridine derivatives
|
|
WO2002004426A1
(en)
|
2000-07-07 |
2002-01-17 |
Celltech R & D Limited |
Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
|
|
US6794506B2
(en)
|
2000-07-21 |
2004-09-21 |
Elan Pharmaceuticals, Inc. |
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
|
|
US6803370B2
(en)
|
2000-07-21 |
2004-10-12 |
Elan Pharmaceuticals, Inc. |
Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4
|
|
PE20020384A1
(es)
|
2000-07-21 |
2002-05-28 |
Schering Corp |
PEPTIDOS COMO INHIBIDORES DE LA PROTEASA SERINA NS3/NS4a DEL VIRUS DE LA HEPATITIS C
|
|
TWI284539B
(en)
|
2001-07-30 |
2007-08-01 |
Epix Pharm Inc |
A method for making a magnetic resonance (MR) imaging agent, a MR imaging contrast agent, a method for altering stability of a peptide and a modified peptide
|
|
WO2003019136A2
(en)
|
2001-08-06 |
2003-03-06 |
The Regents Of The University Of California |
Methods for inhibiting angiogenesis
|
|
AR038136A1
(es)
|
2002-01-24 |
2004-12-29 |
Merck Frosst Canada Inc |
Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
|
|
KR20040105740A
(ko)
|
2002-02-25 |
2004-12-16 |
엘란 파마슈티칼스, 인크. |
염증 치료제의 투여 방법
|
|
TW200307671A
(en)
|
2002-05-24 |
2003-12-16 |
Elan Pharm Inc |
Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
|
|
TWI281470B
(en)
|
2002-05-24 |
2007-05-21 |
Elan Pharm Inc |
Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
|
|
AU2003284984B2
(en)
|
2002-10-30 |
2008-10-23 |
Merck Sharp & Dohme Corp. |
Gamma-aminoamide modulators of chemokine receptor activity
|
|
JP2007521249A
(ja)
|
2003-01-24 |
2007-08-02 |
エラン ファーマシューティカルズ,インコーポレイテッド |
脱髄疾患および麻痺のための組成物ならびに再有髄化剤を投与することによるそれらの治療
|
|
EP1706399A1
(de)
|
2004-01-23 |
2006-10-04 |
Elan Pharmaceuticals, Inc. |
Polyethylenglycolkonjugate von heterocycloalkylcarboxamidopropansäuren
|
|
ES2431524T3
(es)
|
2004-04-13 |
2013-11-26 |
Incyte Corporation |
Derivados de piperazinilpiperidina como antagonistas de los receptores de quimiocinas
|
|
WO2005111020A2
(en)
|
2004-04-30 |
2005-11-24 |
Elan Pharmaceuticals, Inc. |
Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by vla-4
|
|
EP1901778A2
(de)
|
2005-07-08 |
2008-03-26 |
Elan Pharmaceuticals Inc. |
Herstellung von polymerkonjugaten von therapeutischen und landwirtschaftlichen verbindungen sowie lebensmittelzusatzverbindungen
|
|
ATE493405T1
(de)
|
2005-09-29 |
2011-01-15 |
Elan Pharm Inc |
Pyrimidinylamidverbindungen, die die durch vla-4 vermittelte leukozytenadhäsion inhibieren
|
|
ZA200803016B
(en)
|
2005-09-29 |
2009-10-28 |
Elan Pharmaceuticals Inc Wyeth |
Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
MEP1008A
(xx)
|
2005-12-21 |
2010-02-10 |
Incyte Corp |
3-aminociklopentankarboksamidi kao modulatori receptora hemokina
|
|
EA017110B1
(ru)
|
2006-02-27 |
2012-09-28 |
Элан Фамэсьютикэлс, Инк. |
ПИРИМИДИНИЛСУЛЬФОНАМИДНЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ ПИРИМИДИНИЛСУЛЬФОНАМИДНЫХ СОЕДИНЕНИЙ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, ОПОСРЕДОВАННОГО ИНТЕГРИНОМ α4, СПОСОБ СНИЖЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ВОСПАЛИТЕЛЬНОГО КОМПОНЕНТА ЗАБОЛЕВАНИЯ ИЛИ АУТОИММУННОГО ОТВЕТА
|
|
GB0724953D0
(en)
*
|
2007-12-20 |
2008-01-30 |
Lytix Biopharma As |
Methods of peptide modification
|
|
WO2010031183A1
(en)
|
2008-09-22 |
2010-03-25 |
Merck Frosst Canada Ltd. |
Indole derivatives as crth2 receptor antagonists
|
|
PL2370442T3
(pl)
|
2008-11-26 |
2013-08-30 |
Pfizer |
3-Aminocyklopentanokarboksamidy jako modulatory receptora chemokiny
|
|
SG172857A1
(en)
|
2009-02-09 |
2011-08-29 |
Supergen Inc |
Pyrrolopyrimidinyl axl kinase inhibitors
|
|
MA33134B1
(fr)
|
2009-02-24 |
2012-03-01 |
Merck Canada Inc |
Derives d'indole en tant qu'antagonistes du recepteur crth2
|
|
SG10201401836RA
(en)
|
2009-04-27 |
2014-10-30 |
Elan Pharm Inc |
Pyridinone antagonists of alpha-4 integrins
|
|
EP2467159A1
(de)
|
2009-08-20 |
2012-06-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Vla-4 als biomarker zur prognose und target zur behandlung der duchenne-muskeldystrophie
|
|
US8927559B2
(en)
|
2010-10-11 |
2015-01-06 |
Merck Sharp & Dohme Corp. |
Quinazolinone-type compounds as CRTH2 antagonists
|
|
BR112013015397A2
(pt)
|
2010-12-23 |
2016-09-20 |
Merck Sharp & Dohme |
composto, composição farmacêutica, e, uso de um composto
|
|
WO2012151137A1
(en)
|
2011-05-04 |
2012-11-08 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
|
PH12013502619A1
(en)
|
2011-06-17 |
2014-02-17 |
Merck Sharp & Dohme |
Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators
|
|
US8987456B2
(en)
|
2011-10-05 |
2015-03-24 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
|
WO2018140510A1
(en)
|
2017-01-25 |
2018-08-02 |
Biogen Ma Inc. |
Compositions and methods for treatment of stroke and other cns disorders
|
|
WO2020143793A1
(zh)
|
2019-01-10 |
2020-07-16 |
石药集团中奇制药技术(石家庄)有限公司 |
杂环化合物盐及其应用
|
|
US20240301512A1
(en)
|
2021-01-29 |
2024-09-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of assessing the risk of developing progressive multifocal leukoencephalopathy in patients treated with vla-4 antagonists
|